Načítá se...
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages a...
Uloženo v:
| Vydáno v: | Exp Mol Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6082857/ https://ncbi.nlm.nih.gov/pubmed/30089794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-018-0115-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|